UTC 2019 BioVentureFund
Overview
UTC 2019 BIOVENTUREFUND is a South Korean venture capital firm specializing in biotechnology investments, particularly in the healthcare sector. The firm focuses on early-stage and growth-stage startups in technology-based industries such as bio and healthcare, beauty, semiconductors, and artificial intelligence. UTC 2019 BIOVENTUREFUND aims to support domestic startups preparing to expand overseas, including into the Japanese market. The firm has a track record of investing in companies developing innovative technologies with high growth potential, leveraging its team of industry specialists to provide practical support to portfolio companies. UTC 2019 BIOVENTUREFUND has invested in companies such as Solmedix, Humanscape, Immunemed, LifeSemantics, Brexogen, and Pharos Biotech. The firm has a history of successful investments, including a €20 million funding round for PDC*line Pharma in 2020. UTC 2019 BIOVENTUREFUND is headquartered in Seoul, South Korea, and operates under the management of UTC Investment Co., Ltd., which was founded in 1988 and has a total AUM of over 778 billion won. The firm's investment philosophy emphasizes transparency and integrity, aiming to create long-term value for investors and portfolio companies. UTC 2019 BIOVENTUREFUND continues to actively seek investment opportunities in the biotechnology and healthcare sectors, both domestically and internationally.
Investment Focus
- Innovative technologies with high growth potential
- Strong management teams
- Scalable business models
- Potential for international expansion
- Alignment with UTC 2019 BIOVENTUREFUND's investment focus areas
Portfolio Companies
Reach UTC 2019 BioVentureFund directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about UTC 2019 BioVentureFund
What sectors does UTC 2019 BioVentureFund invest in?
UTC 2019 BioVentureFund invests in Healthcare, Artificial Intelligence, Life Sciences, Digital Health, Pharmaceuticals and Medical Devices, and is based in United States. UTC 2019 BioVentureFund is listed as a venture capital in the ConnectSafely investor database.
What stage does UTC 2019 BioVentureFund invest at?
UTC 2019 BioVentureFund backs companies at Seed, Early Stage and Growth, writing cheques of 1M - 50M.
Which regions does UTC 2019 BioVentureFund invest in?
UTC 2019 BioVentureFund invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has UTC 2019 BioVentureFund invested in?
UTC 2019 BioVentureFund's portfolio includes Humanscape, Solmedix, Immunemed, LifeSemantics, Brexogen and Pharos Biotech.
How do I contact UTC 2019 BioVentureFund?
UTC 2019 BioVentureFund's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
